Market Tracker

06/24 5:16pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

8.06
Delayed Data
As of Jun 24
 -0.65 / -7.46%
Today’s Change
5.57
Today|||52-Week Range
10.95
-25.30%
Year-to-Date
Can These Upstarts Knock Gilead Sciences Off Its Perch?
Jun 22 / MotleyFool.com - Paid Partner Content
Why Achillion Pharmaceuticals Is Down Big in 2016
Jun 20 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close8.71
Today’s open8.25
Day’s range8.04 - 8.44
Volume1,628,047
Average volume (3 months)1,526,426
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+94.29%
Earnings growth (this year)-1,517.86%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales20.49
Price/Book2.56

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...-1.07-4.07%
CXRXConcordia Healthcare...-2.64-11.00%
TBPHTheravance Biopharma...-0.48-2.08%
INVAInnoviva Inc-0.90-8.02%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$66.1M
Annual profit (last year)-$5.0M
Net profit margin-7.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Executive VP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts